Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout Newsletter

Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout Newsletter


Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. At the start of this week, my editor said the news flow was looking slow. He’s jinxed us yet again. Let’s get into all the news today.

Billionaire-backed VC firm launches, led by former Flagship associate

From my colleague Allison DeAngelis: Private equity billionaire Tony James is backing a new life sciences investment firm that launched today, the firm told STAT exclusively.

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *